USD 3.35
(4.69%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 6.49 Million USD | -64.9% |
2022 | 18.5 Million USD | 2.78% |
2021 | 18 Million USD | 127.5% |
2020 | 7.91 Million USD | 62.76% |
2019 | 4.86 Million USD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | 7.73 Million USD | 19.17% |
2024 Q2 | 8.1 Million USD | 4.69% |
2023 Q2 | 12.38 Million USD | -15.72% |
2023 Q3 | 11 Million USD | -11.21% |
2023 Q1 | 14.7 Million USD | -20.54% |
2023 FY | 6.49 Million USD | -64.9% |
2023 Q4 | 6.49 Million USD | -40.97% |
2022 Q3 | 23.78 Million USD | -19.09% |
2022 Q4 | 18.5 Million USD | -22.23% |
2022 FY | 18.5 Million USD | 2.78% |
2022 Q1 | 24.71 Million USD | 37.29% |
2022 Q2 | 29.4 Million USD | 18.97% |
2021 Q3 | 10.22 Million USD | -7.47% |
2021 FY | 18 Million USD | 127.5% |
2021 Q4 | 18 Million USD | 76.04% |
2021 Q2 | 11.05 Million USD | 4.42% |
2021 Q1 | 10.58 Million USD | 33.76% |
2020 FY | 7.91 Million USD | 62.76% |
2020 Q2 | - USD | 0.0% |
2020 Q3 | - USD | 0.0% |
2020 Q1 | - USD | 0.0% |
2020 Q4 | 7.91 Million USD | 0.0% |
2019 FY | 4.86 Million USD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Abbott Laboratories | 6.57 Billion USD | 99.901% |
Allurion Technologies Inc. | 6.17 Million USD | -5.218% |
Artivion, Inc. | 81.97 Million USD | 92.079% |
Avanos Medical, Inc. | 163.2 Million USD | 96.021% |
Butterfly Network, Inc. | 75.83 Million USD | 91.438% |
Butterfly Network, Inc. | 75.83 Million USD | 91.438% |
Bio-Rad Laboratories, Inc. | 780.51 Million USD | 99.168% |
Boston Scientific Corporation | 2.48 Billion USD | 99.739% |
CONMED Corporation | 318.32 Million USD | 97.96% |
Edwards Lifesciences Corporation | 1.16 Billion USD | 99.444% |
Paragon 28, Inc. | 98.06 Million USD | 93.379% |
Glaukos Corporation | 41.98 Million USD | 84.535% |
Globus Medical, Inc. | 848.13 Million USD | 99.234% |
Inspire Medical Systems, Inc. | 33.88 Million USD | 80.838% |
Integer Holdings Corporation | 239.71 Million USD | 97.291% |
Medtronic plc | 5.21 Billion USD | 99.876% |
Myomo, Inc. | 1.8 Million USD | -260.021% |
Nevro Corp. | 118.67 Million USD | 94.529% |
Penumbra, Inc. | 388.02 Million USD | 98.327% |
Vicarious Surgical Inc. | - USD | -Infinity% |
Smith & Nephew plc | 2.39 Billion USD | 99.729% |
Sonendo, Inc. | 11.07 Million USD | 41.367% |
STERIS plc | 674.53 Million USD | 99.037% |
Stryker Corporation | 4.84 Billion USD | 99.866% |
Vapotherm, Inc. | 22.96 Million USD | 71.73% |
Zimmer Biomet Holdings, Inc. | 2.38 Billion USD | 99.728% |